Professor Canary received his Ph.D. under the direction of Donald Cram at the University of California at Los Angeles. He joined the New York University faculty in 1991 after completing an NIH postdoctoral fellowship with Ronald Breslow at Columbia University.
Professor Canary's work and interests span a wide range; from synthetic chemistry to chiroptical spectroscopy to biomedical imaging. He is especially known for ligand design and synthesis with an emphasis on stereodynamic coordination chemistry. He teaches undergraduate advanced inorganic/organic laboratory and graduate organic chemistry courses.
Dr. James W. Canary's group consists of interdisciplinary scientists who are interested in the control of the physical properties of materials by noncovalent interactions, stereochemistry, and molecular dynamics. Molecular modeling (including computational and graphical techniques) is used for the rational design of molecules with novel chemical properties. The molecules are then prepared by organic synthesis, and their properties are evaluated using a variety of methods.
One interest is in stereochemistry and molecular chirality, particulary in the use of stereodynamics to control the properties of materials. The vast majority of molecules in biology contain chiral centers, and in most cases, molecular chirality is central to the properties of naturally occurring compounds. However, far fewer compounds used in materials science are chiral. It seems likely that in the future that increasing complexity of synthetic materials will include unique compounds with novel properties arising from stereodynamics.
These interests in stereochemically unique, functional materials have led to investigations of molecular sensors and switches. Materials responsive to their environment can be used as sensors. Conversely, molecules that can influence their environment can be employed as actuators. Both types of application have been the focus of our research effort in recent years.
Studies of sensors have led recently to collaborations at the NYU School of Medicine related to molecular imaging. Research in this area requires highly interdisciplinary research teams, and we are fortunate to have at NYU a team of physicists, chemists, molecular biologists, pharmacologists, oncologists, neurobiologists, and radiologists working together on several projects in this exciting field.